Exhibited at Vitafoods- Europe 2023 with full enthusiasm & fantastic meetings. CHERESO got the opportunity to engage with the global pharmaceutical community and present the innovative and specialty products developed and manufactured by our Organization.
Exhibited at CPHI Japan which was held at Tokyo Big Sight with full enthusiasm & fantastic meetings. Introduced our innovative products & explore more opportunities to grow.
We, Chemical Resources are the Finalist of CPHI Pharma Awards 2022 for API Development product- Thiocolchicoside Chereso has developed an in-house fermentation method to gear especially towards production of Thiocolchiocosides among its wide array of premium quality ingredients. With our expanded manufacturing capacities, we are a reliable partner to provide this product with credibility. Supported…
CHERESO continued its successful presence as an exhibitor at CPhI- Worldwide which is the world’s largest global pharmaceutical exhibition. It was held at Messe Frankfurt, Germany from 1 – 3 November 2022 and united thousands of pharma professionals and suppliers from more than 170 countries, in the presence of more than 1,400 international exhibitors. CHERESO…
Exhibited at Vitafoods- Europe 2022 after a long period with full enthusiasm & fantastic meetings. Introduced our innovative products & explore more opportunities to grow.
Certificate of Suitability (CEP) for the API Thiocolchicosides has been granted. Chereso is among the top companies to receive the CEP from the European Directorate for the Quality of Medicines (EDQM). With our expanded manufacturing capacities, this certificate makes us a reliable partner to provide the product with credibility.
We are delighted and proud to announce that our product Reserpine (Rauwolfia Vomitoria) has been granted DMF in China. DMF No.: JYMS1700007
It is an immense pleasure to share this news that our Research Scholar – Ms. Manpreet Kaur working under the Prime Minister Research Fellowship (an initiative of FICCI and SERB) with our company on the topic “Biochemical Characterization of Euryhaline Microalgal Strina for Bioactive Metabolites” under the guidance of Dr Surekha Bhatia, Senior Biochemist, department…
We have been granted the following Patents for ‘A Single herb extract for the treatment of PCOS (Polycystic Ovarian Syndrome)’ Country Patent No. FRANCE & POLAND EP3233100B1 GERMANY 602015070972.1 ITALY 502021000080333 CHINA CN109152729B
We are happy to announce that we have been granted a patent for our innovation – ‘Process for Extracting Alpha Yohimbine (Rauwolscine) from Rauwolfia Species’ in the United States. MORE TO COME!